Danaher Corporation

Silvernail Elected International Paper Chief Executive Officer

Retrieved on: 
Tuesday, March 19, 2024
Culture, Growth, Danaher Corporation, Stryker Corporation, International Paper, George Silvernail, IP, IDEX Corporation, KKR, Newell Brands, Management

MEMPHIS, Tenn., March 19, 2024 /PRNewswire/ -- International Paper (NYSE: IP) today announced that its board of directors has elected Andrew Silvernail as Chief Executive Officer (CEO), following an extensive evaluation process. Effective May 1, 2024, Silvernail will succeed Mark Sutton, who previously announced the final phase of the CEO succession process. Sutton will continue in his role as Chairman of the International Paper Board of Directors to ensure a smooth and successful transition.

Key Points: 
  • MEMPHIS, Tenn., March 19, 2024 /PRNewswire/ -- International Paper (NYSE: IP) today announced that its board of directors has elected Andrew Silvernail as Chief Executive Officer (CEO), following an extensive evaluation process.
  • Sutton will continue in his role as Chairman of the International Paper Board of Directors to ensure a smooth and successful transition.
  • International Paper Lead Director Chris Connor said, "Andy is an experienced CEO with an extensive track record for creating value.
  • Andy Silvernail, CEO-Elect of International Paper , said, "I'm honored and proud to be a part of International Paper, a strong and resilient company and a force for good in communities around the world.

Molecular Devices Appoints Mary Duseau as President, Bringing 25 Years of Experience in Life Sciences

Retrieved on: 
Wednesday, March 13, 2024
Health, Detection, Communication, PerkinElmer, Danaher Corporation, SAN, Leica Biosystems, University, Senior, Biology, Marketing, Molecular Devices, DHR, Pharmaceutical industry

SAN JOSE, Calif., March 13, 2024 /PRNewswire-PRWeb/ -- Molecular Devices, LLC., a leading high-performance life science solutions provider and an operating company in the life sciences segment of Danaher Corporation (NYSE:DHR), today announced Mary Duseau's appointment as its new president, succeeding interim president, Greg Milosevich.

Key Points: 
  • , a leading high-performance life science solutions provider and an operating company in the life sciences segment of Danaher Corporation (NYSE:DHR), today announced Mary Duseau's appointment as its new president, succeeding interim president, Greg Milosevich.
  • "Mary brings more than 25 years of life science experience and a track record of achieving exceptional business results to Molecular Devices," said Greg Milosevich, Vice President, and Group Executive Life Sciences Innovations Group at Danaher Corporation.
  • Prior to joining Molecular Devices, Mary spent six years at Leica Biosystems, also a Danaher operating company.
  • "In this short time as president, it's clear that Molecular Devices' innovative technology and diverse team are enabling a revolution of human health – and that's really inspiring," said Mary Duseau, President of Molecular Devices.

DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, February 26, 2024
Biotechnology, Telephone, News, Biophysical environment, Growth, Projection, Vaccine, COVID-19, Danaher Corporation, DHR, Research, P.C, Pharmaceutical industry

Our investigation concerns whether the board of directors of Danaher have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of Danaher have breached their fiduciary duties to the company.
  • Danaher designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
  • The Company is comprised of more than 20 operating companies organized under four segments: Biotechnology; Life Sciences; Diagnostics; and Environmental & Applied Solutions.
  • On April 25, 2023, Danaher issued a press release announcing its financial results for the first quarter of 2023.

United States Medical Diagnostics Research Report 2024: Market Impacts of Surging Adoption of Healthcare Wearables and Rising Integration with Artificial Intelligence - Forecasts to 2028 - ResearchAndMarkets.com

Retrieved on: 
Friday, March 8, 2024
Biotechnology, Health, Technology, Health Technology, Artificial Intelligence, Hospital, Pandemic, PMA, POC, Growth, EHR, Conditional sentence, Urbanization, BioMérieux, Quest Diagnostics, COVID-19, Product type, Abbott Laboratories, Automation, Danaher Corporation, Roche, Artificial intelligence, IVD, Medical device

A few notable trends include surging adoption of healthcare related devices like wearables, emergence of various pandemic diseases, rising integration with Artificial Intelligence and growing awareness for personalized medicine.

Key Points: 
  • A few notable trends include surging adoption of healthcare related devices like wearables, emergence of various pandemic diseases, rising integration with Artificial Intelligence and growing awareness for personalized medicine.
  • The U.S. medical diagnostics market has been segmented on the basis of type, product type and end-users.
  • Depending on the product type, the U.S. medical diagnostics market can be segmented into reagents, instruments and software & services.
  • The report provides a comprehensive analysis of the U.S. medical diagnostics market segmented on the basis of type, product type, end users and region.

Women in Manufacturing Association Announces 2024 Board of Directors

Retrieved on: 
Monday, March 4, 2024
Other Manufacturing, Women, Steel, Engineering, Automotive Manufacturing, Manufacturing, Machinery, Machine Tools, Metalworking & Metallurgy, Consumer, Diebold Nixdorf, KeyBank, Woman, Health, Human, Business process, Molson Coors, Trane Technologies, Occupational safety and health, Kohler Co., Continual improvement process, GE Appliances, Danaher Corporation, Environment, PepsiCo, Management

The Women in Manufacturing® Association (WiM) is pleased to announce the election of 20 members to its 2024 Board of Directors, who begin their terms on April 1, 2024.

Key Points: 
  • The Women in Manufacturing® Association (WiM) is pleased to announce the election of 20 members to its 2024 Board of Directors, who begin their terms on April 1, 2024.
  • WiM is the only national and global trade association specifically dedicated to supporting, promoting and inspiring women who have chosen a career in the manufacturing sector.
  • The Women in Manufacturing® Association is a more than 26,000-member-strong association dedicated to supporting, promoting and inspiring women who have chosen a career in the manufacturing industry.
  • It encourages the engagement of women who want to share perspectives, gain cutting-edge manufacturing information, improve leadership and communication skills, participate in sponsoring programs and network with industry peers.

Soundcore Capital Partners Appoints Brian Pfeifer as President of Door & Dock Holdings

Retrieved on: 
Monday, March 4, 2024
Acquisition, Growth, D&D, Danaher Corporation, Top Notch

NEW YORK, March 4, 2024 /PRNewswire/ -- Soundcore Capital Partners, LP ("Soundcore"), a New York-based private equity firm specializing in buy-and-build investments in the lower middle-market, is pleased to announce the appointment of Brian Pfeifer as President of Door & Dock Holdings, LLC ("D&D").

Key Points: 
  • NEW YORK, March 4, 2024 /PRNewswire/ -- Soundcore Capital Partners, LP ("Soundcore"), a New York-based private equity firm specializing in buy-and-build investments in the lower middle-market, is pleased to announce the appointment of Brian Pfeifer as President of Door & Dock Holdings, LLC ("D&D").
  • D&D is a leading provider of installation, repair and maintenance services for residential garage doors and commercial overhead door, dock leveler and access control solutions.
  • In January 2024, D&D added a third business with the acquisition of Select Door Services in the North Atlanta market.
  • The businesses consolidated under the Top Notch Dock and Door brand in the commercial market and Top Notch Garage Door in the residential market.

Danaher to Present at TD Cowen Health Care Conference

Retrieved on: 
Tuesday, February 27, 2024
Danaher Corporation, DHR, Conference

WASHINGTON, Feb. 27, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, March 5, 2024 at 11:10 a.m.

Key Points: 
  • WASHINGTON, Feb. 27, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, March 5, 2024 at 11:10 a.m.
  • ET.
  • The event will be simultaneously webcast on www.danaher.com .

Lateral Flow Assays Market Worth $16.8 billion | MarketsandMarkets™

Retrieved on: 
Monday, February 26, 2024
SARS-CoV-2, Investment, FDA, Growth, High, PerkinElmer, Food, Antibody, Pulse, SARS, COVID-19, FIA, Abbott Laboratories, QuidelOrtho, Danaher Corporation, Infection, Consistency, Market development

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=167205133

Key Points: 
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=167205133
    Lateral Flow Assays Market - Key Benefits of Buying the Report:
    The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall lateral flow assays market and the subsegments.
  • This report provides insights into the following pointers:
    Analysis of key drivers (High prevalence of infectious diseases, increasing of the geriatric population, Growing use of home-based lateral flow assays devices, Growing demand for point of care testing and need for rapid diagnostic testing for COVID-19), restraints (Inconsistent results of lateral flow analysis), opportunities (evolving application of lateral flow assays, rising demand for lateral flow assays in the food and beverage industries) and challenges limited reimbursements for lateral flow assay products and difficulty in procuring quality raw materials for the development of lateral flow assays tests) influencing the growth of the lateral flow assays market.
  • Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the lateral flow assays market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the lateral flow assays market.

Lateral Flow Assays Market Worth $16.8 billion | MarketsandMarkets™

Retrieved on: 
Monday, February 26, 2024
SARS-CoV-2, Investment, FDA, Growth, High, PerkinElmer, Food, Antibody, Pulse, SARS, COVID-19, FIA, Abbott Laboratories, QuidelOrtho, Danaher Corporation, Infection, Consistency, Market development

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=167205133

Key Points: 
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=167205133
    Lateral Flow Assays Market - Key Benefits of Buying the Report:
    The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall lateral flow assays market and the subsegments.
  • This report provides insights into the following pointers:
    Analysis of key drivers (High prevalence of infectious diseases, increasing of the geriatric population, Growing use of home-based lateral flow assays devices, Growing demand for point of care testing and need for rapid diagnostic testing for COVID-19), restraints (Inconsistent results of lateral flow analysis), opportunities (evolving application of lateral flow assays, rising demand for lateral flow assays in the food and beverage industries) and challenges limited reimbursements for lateral flow assay products and difficulty in procuring quality raw materials for the development of lateral flow assays tests) influencing the growth of the lateral flow assays market.
  • Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the lateral flow assays market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the lateral flow assays market.

Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets

Retrieved on: 
Thursday, February 22, 2024
World Resources Institute, WRI, Climate, Targets, WWF, United Nations Global Compact, CDP, Health, Science Based Targets initiative, Danaher Corporation, DHR, Science, GHG, Partnership, Renewable energy

WASHINGTON, Feb. 22, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (Danaher) announced today it has committed to set science-based greenhouse gas (GHG) emission reduction targets in line with the Science Based Targets initiative (SBTi), including a long-term target to reach net-zero value chain emissions by no later than 2050.

Key Points: 
  • WASHINGTON, Feb. 22, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (Danaher) announced today it has committed to set science-based greenhouse gas (GHG) emission reduction targets in line with the Science Based Targets initiative (SBTi), including a long-term target to reach net-zero value chain emissions by no later than 2050.
  • Danaher's pledge encompasses Scope 1, 2 and 3 GHG emissions and complements its existing commitment to reduce Scope 1 and 2 GHG emissions on an absolute basis by 50.4% by 2032 compared to 2021.
  • "At the heart of everything we do at Danaher is continuous improvement, and our sustainability program further exemplifies this commitment," said Rainer M. Blair, Danaher's President and Chief Executive Officer.
  • Danaher will submit its GHG emission reduction targets to SBTi to be validated against the SBTi criteria.